Jan 18, 2014, 04.21 PM IST
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
Tags Biocon, Herceptin
Like this story, share it with millions of investors on M3
Biocon to start selling breast cancer drug in India in Feb
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
Like this story, share it with millions of investors on M3
Biocon to start selling breast cancer drug in India in Feb
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
About 150,000 people are diagnosed with breast cancer every year in India, of which 25 percent are eligible for treatment with trastuzumab, Biocon said.
Roche decided not to pursue a patent application for its breast cancer drug Herceptin in India, paving the way for generic drugmakers to produce cheaper copies, known as biosimilars because they are not identical to the original drug.
Global sales for Herceptin were valued at about USD 6.4 billion in 2012, including about USD 21 million in India, Biocon said.
Biocon stock price
On January 17, 2014, Biocon closed at Rs 441.50, down Rs 21.85, or 4.72 percent. The 52-week high of the share was Rs 491.70 and the 52-week low was Rs 255.00.
The company's trailing 12-month (TTM) EPS was at Rs 15.02 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 29.39. The latest book value of the company is Rs 110.34 per share. At current value, the price-to-book value of the company is 4.00.
Anda sedang membaca artikel tentang
Biocon to start selling breast cancer drug in India in Feb
Dengan url
http://gayafashionshow.blogspot.com/2014/01/biocon-to-start-selling-breast-cancer.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Biocon to start selling breast cancer drug in India in Feb
namun jangan lupa untuk meletakkan link
Biocon to start selling breast cancer drug in India in Feb
sebagai sumbernya
0 komentar:
Posting Komentar